Obesity

>

Latest News

Setmelanotide demonstrates BMI reduction in patients with acquired hypothalamic obesity | Image Credit: © rangizzz - © rangizzz - stock.adobe.com.
Setmelanotide demonstrates BMI reduction in patients with acquired hypothalamic obesity

April 7th 2025

In the phase 3 TRANSCEND trial, setmelanotide met the primary endpoint of a statistically significant and clinically meaningful BMI reduction compared to placebo.

Clinician quiz: AAP clinical practice guideline for treatment of children with obesity | Image Credit: © Daqota - © Daqota - stock.adobe.com.
Clinician quiz: AAP clinical practice guideline for treatment of children with obesity

March 4th 2025

Colleen Sloan, PA-C, RDN
Reading between the lines: teaching teens to use nutrition facts labels

March 4th 2025

Racial, ethnic disparities exist when counseling on nutrition, lifestyle, and weight | Image Credit: © Pixel-Shot - © Pixel-Shot - stock.adobe.com.
Racial, ethnic disparities exist when counseling on nutrition, lifestyle, and weight

January 30th 2025

Pediatric obesity treatment yields lower morbidity, mortality risk in young adults | Image Credit: © Felix Pergande - © Felix Pergande - stock.adobe.com.
Pediatric obesity treatment yields lower morbidity, mortality risk in young adults

January 21st 2025

More News

© 2025 MJH Life Sciences

All rights reserved.